Lymphoma Research: 10 LLS Grants You Should Know About



7. Transforming CURES Initiative

The Transforming CURES Initiative (TCI) – Intercepting Progression to Advanced Myeloid Blood Cancers is the result of a partnership between the LLS and Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson. The purpose of the grant is to support research able to identify and develop novel, safe and effective treatment paradigms for patients with hematological malignancies, and it consists of $400,000 over a period of three years.

Find out more here.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published.